General Information of the Compound
Compound ID
CP0392754
Compound Name
(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S,5S,8S,11S,14S,17S,26S,29S,32S)-32-(4-aminobutyl)-26-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-14-(2-amino-2-oxoethyl)-11-[(2S)-butan-2-yl]-2-(3-carbamimidamidopropyl)-29-(hydroxymethyl)-8-[(4-hydroxyphenyl)methyl]-5-(1H-imidazol-5-ylmethyl)-3,6,9,12,15,23,27,30,33,40-decaoxo-1,4,7,10,13,16,22,28,31,34-decazacyclotetracontane-17-carbonyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid
    Show/Hide
Structure
Formula
C102H160N32O26
Molecular Weight
2250.6
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCCCCCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O
    Show/Hide
InChI
InChI=1S/C102H160N32O26/c1-6-54(3)81-96(156)129-74(50-78(106)141)93(153)124-67(91(151)132-82(55(4)7-2)97(157)134-83(56(5)136)98(158)126-69(22-17-45-118-102(111)112)87(147)125-70(36-38-77(105)140)89(149)123-68(21-16-44-117-101(109)110)88(148)130-75(99(159)160)48-59-28-34-63(139)35-29-59)19-11-14-41-114-79(142)39-37-71(121-84(144)64(104)46-57-24-30-61(137)31-25-57)90(150)131-76(52-135)95(155)122-65(18-10-12-40-103)85(145)115-42-13-8-9-23-80(143)120-66(20-15-43-116-100(107)108)86(146)128-73(49-60-51-113-53-119-60)92(152)127-72(94(154)133-81)47-58-26-32-62(138)33-27-58/h24-35,51,53-56,64-76,81-83,135-139H,6-23,36-50,52,103-104H2,1-5H3,(H2,105,140)(H2,106,141)(H,113,119)(H,114,142)(H,115,145)(H,120,143)(H,121,144)(H,122,155)(H,123,149)(H,124,153)(H,125,147)(H,126,158)(H,127,152)(H,128,146)(H,129,156)(H,130,148)(H,131,150)(H,132,151)(H,133,154)(H,134,157)(H,159,160)(H4,107,108,116)(H4,109,110,117)(H4,111,112,118)/t54-,55-,56+,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,81-,82-,83-/m0/s1
    Show/Hide
InChIKey
ROSXYSDJZUJAFR-QCETVNLESA-N
Physicochemical Property
logP
-8.23709
Rotatable Bonds
50
Heavy Atom Count
160
Polar Areas
985.75
Hydrogen Bond Donor Count
37
Hydrogen Bond Acceptor Count
31
Complexity
160

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145981742
ChEMBL ID
CHEMBL4281010
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 > 1000 nM
   TI
   LI
   LO
   TS
Protein ID: PT01909, Neuropeptide Y receptor type 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 > 1000 nM
   TI
   LI
   LO
   TS